Abcr Kimyasalları
Toplam 24 ürün listeleniyor
| Ürün Kodu | Ürün Adı | Ürün Fiyatı | |
|
AB348753-1MG |
Adrenocorticotropic Hormone (1-39), guinea pig. (CAS No: )Adrenocorticotropic Hormone (1-39), guinea pig. (CAS No: ) |
|
AB348753-1MGAdrenocorticotropic Hormone (1-39), guinea pig. (CAS No: )Adrenocorticotropic Hormone (1-39), guinea pig. (CAS No: ) |
|||
|
|
AB350950-5MG |
Bradykinin (1-3). (CAS No: )Bradykinin (1-3). (CAS No: ) |
|
AB350950-5MGBradykinin (1-3). (CAS No: )Bradykinin (1-3). (CAS No: ) |
|||
|
|
AB249220-100MG |
Diphenyl(m-sulfonatophenyl)phosphine-gold nanocluster (water soluble) (1-3 nm). (CAS No: )Diphenyl(m-sulfonatophenyl)phosphine-gold nanocluster (water soluble) (1-3 nm). (CAS No: ) |
|
AB249220-100MGDiphenyl(m-sulfonatophenyl)phosphine-gold nanocluster (water soluble) (1-3 nm). (CAS No: )Diphenyl(m-sulfonatophenyl)phosphine-gold nanocluster (water soluble) (1-3 nm). (CAS No: ) |
|||
|
|
AB249220-500MG |
Diphenyl(m-sulfonatophenyl)phosphine-gold nanocluster (water soluble) (1-3 nm). (CAS No: )Diphenyl(m-sulfonatophenyl)phosphine-gold nanocluster (water soluble) (1-3 nm). (CAS No: ) |
|
AB249220-500MGDiphenyl(m-sulfonatophenyl)phosphine-gold nanocluster (water soluble) (1-3 nm). (CAS No: )Diphenyl(m-sulfonatophenyl)phosphine-gold nanocluster (water soluble) (1-3 nm). (CAS No: ) |
|||
|
|
AB261633-5MG |
Gal beta(1-3)GalNAc beta(1-3)Gal alpha(1-4)Gal beta(1-4)Glc-beta-pNP. (CAS No: )Gal beta(1-3)GalNAc beta(1-3)Gal alpha(1-4)Gal beta(1-4)Glc-beta-pNP. (CAS No: ) |
|
AB261633-5MGGal beta(1-3)GalNAc beta(1-3)Gal alpha(1-4)Gal beta(1-4)Glc-beta-pNP. (CAS No: )Gal beta(1-3)GalNAc beta(1-3)Gal alpha(1-4)Gal beta(1-4)Glc-beta-pNP. (CAS No: ) |
|||
|
|
AB331772-5MG |
Gal beta(1-3)GalNAc-alpha-pNP; 97%. (CAS No: 59837-14-8)Gal beta(1-3)GalNAc-alpha-pNP; 97%. (CAS No: 59837-14-8) |
|
AB331772-5MGGal beta(1-3)GalNAc-alpha-pNP; 97%. (CAS No: 59837-14-8)Gal beta(1-3)GalNAc-alpha-pNP; 97%. (CAS No: 59837-14-8) |
|||
|
|
AB261600-5MG |
Gal beta(1-3)GalNAc-alpha-Thr. (CAS No: 60280-58-2)Gal beta(1-3)GalNAc-alpha-Thr. (CAS No: 60280-58-2) |
|
AB261600-5MGGal beta(1-3)GalNAc-alpha-Thr. (CAS No: 60280-58-2)Gal beta(1-3)GalNAc-alpha-Thr. (CAS No: 60280-58-2) |
|||
|
|
AB261624-5MG |
Gal beta(1-3)GalNAc-beta-pNP. (CAS No: 59837-15-9)Gal beta(1-3)GalNAc-beta-pNP. (CAS No: 59837-15-9) |
|
AB261624-5MGGal beta(1-3)GalNAc-beta-pNP. (CAS No: 59837-15-9)Gal beta(1-3)GalNAc-beta-pNP. (CAS No: 59837-15-9) |
|||
|
|
AB261627-5MG |
Gal beta(1-3)GlcNAc beta(1-3)Gal beta(1-4)Glc-beta-pNP. (CAS No: 148705-09-3)Gal beta(1-3)GlcNAc beta(1-3)Gal beta(1-4)Glc-beta-pNP. (CAS No: 148705-09-3) |
|
AB261627-5MGGal beta(1-3)GlcNAc beta(1-3)Gal beta(1-4)Glc-beta-pNP. (CAS No: 148705-09-3)Gal beta(1-3)GlcNAc beta(1-3)Gal beta(1-4)Glc-beta-pNP. (CAS No: 148705-09-3) |
|||
|
|
AB331774-2MG |
Gal beta(1-3)[Neu5Ac alpha(2-6)]GalNAc-alpha-pNP; 95%. (CAS No: 1316822-90-8)Gal beta(1-3)[Neu5Ac alpha(2-6)]GalNAc-alpha-pNP; 95%. (CAS No: 1316822-90-8) |
|
AB331774-2MGGal beta(1-3)[Neu5Ac alpha(2-6)]GalNAc-alpha-pNP; 95%. (CAS No: 1316822-90-8)Gal beta(1-3)[Neu5Ac alpha(2-6)]GalNAc-alpha-pNP; 95%. (CAS No: 1316822-90-8) |
|||
|
|
AB261625-5MG |
Gal beta(1-3)[Neu5Ac alpha(2-6)]GalNAc-beta-pNP. (CAS No: )Gal beta(1-3)[Neu5Ac alpha(2-6)]GalNAc-beta-pNP. (CAS No: ) |
|
AB261625-5MGGal beta(1-3)[Neu5Ac alpha(2-6)]GalNAc-beta-pNP. (CAS No: )Gal beta(1-3)[Neu5Ac alpha(2-6)]GalNAc-beta-pNP. (CAS No: ) |
|||
|
|
AB261632-5MG |
GalNAc beta(1-3)Gal alpha(1-4)Gal beta(1-4)Glc-beta-pNP. (CAS No: 1134635-03-2)GalNAc beta(1-3)Gal alpha(1-4)Gal beta(1-4)Glc-beta-pNP. (CAS No: 1134635-03-2) |
|
AB261632-5MGGalNAc beta(1-3)Gal alpha(1-4)Gal beta(1-4)Glc-beta-pNP. (CAS No: 1134635-03-2)GalNAc beta(1-3)Gal alpha(1-4)Gal beta(1-4)Glc-beta-pNP. (CAS No: 1134635-03-2) |
|||
|
|
AB261616-1GR |
Gal[2346Ac]beta(1-3)GalN3[46Bzd]-beta-MP. (CAS No: )Gal[2346Ac]beta(1-3)GalN3[46Bzd]-beta-MP. (CAS No: ) |
|
AB261616-1GRGal[2346Ac]beta(1-3)GalN3[46Bzd]-beta-MP. (CAS No: )Gal[2346Ac]beta(1-3)GalN3[46Bzd]-beta-MP. (CAS No: ) |
|||
|
|
AB261616-5GR |
Gal[2346Ac]beta(1-3)GalN3[46Bzd]-beta-MP. (CAS No: )Gal[2346Ac]beta(1-3)GalN3[46Bzd]-beta-MP. (CAS No: ) |
|
AB261616-5GRGal[2346Ac]beta(1-3)GalN3[46Bzd]-beta-MP. (CAS No: )Gal[2346Ac]beta(1-3)GalN3[46Bzd]-beta-MP. (CAS No: ) |
|||
|
|
AB261612-1GR |
Gal[2346Ac]beta(1-3)GlcN3[46Bzd]-beta-MP. (CAS No: )Gal[2346Ac]beta(1-3)GlcN3[46Bzd]-beta-MP. (CAS No: ) |
|
AB261612-1GRGal[2346Ac]beta(1-3)GlcN3[46Bzd]-beta-MP. (CAS No: )Gal[2346Ac]beta(1-3)GlcN3[46Bzd]-beta-MP. (CAS No: ) |
|||
|
|
AB261612-5GR |
Gal[2346Ac]beta(1-3)GlcN3[46Bzd]-beta-MP. (CAS No: )Gal[2346Ac]beta(1-3)GlcN3[46Bzd]-beta-MP. (CAS No: ) |
|
AB261612-5GRGal[2346Ac]beta(1-3)GlcN3[46Bzd]-beta-MP. (CAS No: )Gal[2346Ac]beta(1-3)GlcN3[46Bzd]-beta-MP. (CAS No: ) |
|||
|
|
AB261613-1GR |
Gal[2346Ac]beta(1-3)GlcNPhth[46Bzd]-beta-MP. (CAS No: )Gal[2346Ac]beta(1-3)GlcNPhth[46Bzd]-beta-MP. (CAS No: ) |
|
AB261613-1GRGal[2346Ac]beta(1-3)GlcNPhth[46Bzd]-beta-MP. (CAS No: )Gal[2346Ac]beta(1-3)GlcNPhth[46Bzd]-beta-MP. (CAS No: ) |
|||
|
|
AB261613-5GR |
Gal[2346Ac]beta(1-3)GlcNPhth[46Bzd]-beta-MP. (CAS No: )Gal[2346Ac]beta(1-3)GlcNPhth[46Bzd]-beta-MP. (CAS No: ) |
|
AB261613-5GRGal[2346Ac]beta(1-3)GlcNPhth[46Bzd]-beta-MP. (CAS No: )Gal[2346Ac]beta(1-3)GlcNPhth[46Bzd]-beta-MP. (CAS No: ) |
|||
|
|
AB331773-5MG |
GlcNAc beta(1-3)GalNAc-alpha-pNP; 98%. (CAS No: 125455-64-3)GlcNAc beta(1-3)GalNAc-alpha-pNP; 98%. (CAS No: 125455-64-3) |
|
AB331773-5MGGlcNAc beta(1-3)GalNAc-alpha-pNP; 98%. (CAS No: 125455-64-3)GlcNAc beta(1-3)GalNAc-alpha-pNP; 98%. (CAS No: 125455-64-3) |
|||
|
|
AB331775-2MG |
GlcNAc beta(1-3)[Neu5Ac alpha(2-6)]GalNAc-alpha-pNP; 97%. (CAS No: )GlcNAc beta(1-3)[Neu5Ac alpha(2-6)]GalNAc-alpha-pNP; 97%. (CAS No: ) |
|
AB331775-2MGGlcNAc beta(1-3)[Neu5Ac alpha(2-6)]GalNAc-alpha-pNP; 97%. (CAS No: )GlcNAc beta(1-3)[Neu5Ac alpha(2-6)]GalNAc-alpha-pNP; 97%. (CAS No: ) |
|||
|
|
AB261611-1GR |
GlcNPhth[346Ac]beta(1-3)Gal[246Bn]-beta-MP. (CAS No: )GlcNPhth[346Ac]beta(1-3)Gal[246Bn]-beta-MP. (CAS No: ) |
|
AB261611-1GRGlcNPhth[346Ac]beta(1-3)Gal[246Bn]-beta-MP. (CAS No: )GlcNPhth[346Ac]beta(1-3)Gal[246Bn]-beta-MP. (CAS No: ) |
|||
|
|
AB261611-200MG |
GlcNPhth[346Ac]beta(1-3)Gal[246Bn]-beta-MP. (CAS No: )GlcNPhth[346Ac]beta(1-3)Gal[246Bn]-beta-MP. (CAS No: ) |
|
AB261611-200MGGlcNPhth[346Ac]beta(1-3)Gal[246Bn]-beta-MP. (CAS No: )GlcNPhth[346Ac]beta(1-3)Gal[246Bn]-beta-MP. (CAS No: ) |
|||
|
|
AB351037-1MG |
Glucagon Like Peptide-2 (1-33), human. (CAS No: )Glucagon Like Peptide-2 (1-33), human. (CAS No: ) |
|
AB351037-1MGGlucagon Like Peptide-2 (1-33), human. (CAS No: )Glucagon Like Peptide-2 (1-33), human. (CAS No: ) |
|||
|
|
AB261743-1MG |
Neu5Ac alpha(2-6)Gal beta(1-3)GlcNAc-beta-pNP. (CAS No: )Neu5Ac alpha(2-6)Gal beta(1-3)GlcNAc-beta-pNP. (CAS No: ) |
|
AB261743-1MGNeu5Ac alpha(2-6)Gal beta(1-3)GlcNAc-beta-pNP. (CAS No: )Neu5Ac alpha(2-6)Gal beta(1-3)GlcNAc-beta-pNP. (CAS No: ) |
|||
Carlo Erba Kimyasalları
